These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype. Naot D; Wilson LC; Allgrove J; Adviento E; Piec I; Musson DS; Cundy T; Calder AD Bone; 2020 Jan; 130():115098. PubMed ID: 31655221 [TBL] [Abstract][Full Text] [Related]
7. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. Janssens K; de Vernejoul MC; de Freitas F; Vanhoenacker F; Van Hul W Bone; 2005 Mar; 36(3):542-8. PubMed ID: 15777670 [TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin deficiency and juvenile Paget's disease. Whyte MP; Obrecht SE; Finnegan PM; Jones JL; Podgornik MN; McAlister WH; Mumm S N Engl J Med; 2002 Jul; 347(3):175-84. PubMed ID: 12124406 [TBL] [Abstract][Full Text] [Related]
9. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. Hosogane N; Miyamoto T Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037 [TBL] [Abstract][Full Text] [Related]
10. Loss of Functional Osteoprotegerin: More Than a Skeletal Problem. Grasemann C; Unger N; Hövel M; Arweiler-Harbeck D; Herrmann R; Schündeln MM; Müller O; Schweiger B; Lausch E; Meissner T; Kiewert C; Hauffa BP; Shaw NJ J Clin Endocrinol Metab; 2017 Jan; 102(1):210-219. PubMed ID: 27809640 [TBL] [Abstract][Full Text] [Related]
11. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK. Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546 [TBL] [Abstract][Full Text] [Related]
12. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). Polyzos SA; Singhellakis PN; Naot D; Adamidou F; Malandrinou FC; Anastasilakis AD; Polymerou V; Kita M J Clin Endocrinol Metab; 2014 Mar; 99(3):703-7. PubMed ID: 24433001 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251 [TBL] [Abstract][Full Text] [Related]
14. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL. Middleton-Hardie C; Zhu Q; Cundy H; Lin JM; Callon K; Tong PC; Xu J; Grey A; Cornish J; Naot D J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292 [TBL] [Abstract][Full Text] [Related]
16. Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation. Prata AR; Saraiva J; Salgado M; Estanqueiro P Joint Bone Spine; 2021 Dec; 88(6):105243. PubMed ID: 34166796 [TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. Brunetti G; Marzano F; Colucci S; Ventura A; Cavallo L; Grano M; Faienza MF Endocrine; 2012 Oct; 42(2):266-71. PubMed ID: 22638612 [TBL] [Abstract][Full Text] [Related]
18. Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease. Gonc EN; Ozon A; Buyukyilmaz G; Alikasifoglu A; Simsek OP; Kandemir N Osteoporos Int; 2018 Jun; 29(6):1471-1474. PubMed ID: 29502293 [TBL] [Abstract][Full Text] [Related]
19. [Role of OPG in regulation of bone remodeling]. Nakamichi Y; Udagawa N Clin Calcium; 2006 Sep; 16(9):1463-68. PubMed ID: 16951469 [TBL] [Abstract][Full Text] [Related]